Stocks · News reference
HealthEquity Q2 Adj. EPS $1.24 Beats $1.19 Estimate, Sales $350.732M Beat $349.248M Estimate
HealthEquity (NASDAQ:HQY) reported quarterly earnings of $1.24 per share which beat the analyst consensus estimate of $1.19 by 4.2 percent. This is a 14.81 percent increase over earnings of $1.08 per share from the same
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Why HealthEquity Stock Sank This Week
HealthEquity stock fell 8.6% this week despite delivering sales and earnings beats in its fiscal Q2 report. The company posted adjusted EPS of $1.24 on revenue of $350.7 million, both exceeding analyst expectations. However, management's marginal increase to full-year revenue guidance and unchanged adjusted EPS guidance disappointed investors who were expecting stronger forward guidance.
BTIG Reiterates Buy on HealthEquity, Maintains $115 Price Target
BTIG analyst David Larsen reiterates HealthEquity (NASDAQ:HQY) with a Buy and maintains $115 price target.
Crude Oil Moves Higher; Dollar General Shares Gain After Upbeat Q2 Earnings
U.S. stocks traded higher, Dow up 0.20%, NASDAQ up 1.05%, S&P 500 up 0.47%. Tech shares jumped 2.4% while consumer staples fell 1%. Dollar General gained 5% on strong earnings. Propanc Biopharma soared 157%. Okta and Veeva Systems also rose. Build-A-Bear Workshop and Healthequity fell on earnings. European and Asian markets closed mostly lower.